Showing results (271-280 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|November 30, 2023
Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal CarcinomatosisJoost G E Verbeek, Karen van der Sluis, Marieke A Vollebergh, et al.
Pharmacoeconomics - Open|November 24, 2023
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in SwitzerlandAndrea Favre-Bulle, Min Huang, Amin Haiderali, et al.
Pharmacoeconomics - Open|February 10, 2024
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language ModelsTim Reason, William Rawlinson, Julia Langham, et al.
Pharmacoeconomics - Open|January 30, 2024
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant HypertensionRod S Taylor, Anthony Bentley, Kaylie Metcalfe, et al.
Pharmacoeconomics - Open|May 21, 2024
Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature ReviewVittoria Ardito, Ludovico Cavallaro, Michael Drummond, et al.
Pharmacoeconomics - Open|September 27, 2023
Estimating Cumulative Health Care Costs of Childhood and Adolescence Autism Spectrum Disorder in Ontario, Canada: A Population-Based Incident Cohort StudyClaire de Oliveira, Bryan Tanner
Pharmacoeconomics - Open|October 8, 2024
Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USADong-Won Kang, Patricio B Lynn, Li Wang, et al.
Pharmacoeconomics - Open|August 8, 2023
Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in DenmarkAnne Høy Seemann Vestergaard, Lars Holger Ehlers, Mette Asbjoern Neergaard, et al.
Pharmacoeconomics - Open|June 1, 2023
A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in RYi-Shu Lin, James F O'Mahony, Joost van Rosmalen
Pharmacoeconomics - Open|June 8, 2023
Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature ReviewNick Jovanoski, Seye Abogunrin, Danilo Di Maio, et al.
Pageof 61